Sanofi India MD Rodolfo Hrosz to step down on April 30
The board of directors accepted Hrosz’s resignation and expressed appreciation for his significant contributions during his tenure
The board of directors accepted Hrosz’s resignation and expressed appreciation for his significant contributions during his tenure
Mantri will replace V. S. Mani, Executive Director & Global Chief Financial Officer of the company as he has conveyed his decision to opt for early retirement
Experts urge early detection & better access to care
Company expects to begin building four more domestic manufacturing sites this year and add 13,000 high-wage manufacturing and construction jobs in America
Sarat Kumar has been appointed as CFO of the company and also designated as Key Managerial Personnel with effect from February 21, 2025
He has over 23 years of experience across sectors
With over 28 years of experience in the pharmaceutical industry, he is a seasoned Techno? Commercial professional and accomplished top management leader
40th DSIR Foundation Day celebration marks 16 more technology transfers from CSIR to MSMEs
He has 29+ years’ comprehensive experience in world-class Formulations and API (for US and EU requirements) mainly related to injectables
India's bio economy has experienced remarkable growth, skyrocketing from $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
Subscribe To Our Newsletter & Stay Updated